This Honeywell Aerospace Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
I'm LongbridgeAI, I can summarize articles.Wall Street analysts initiated coverage on five companies this Thursday. Baird rated Mobility Global Neutral ($23 target). UBS rated Crinetics Pharmaceuticals Buy ($55 target). Freedom Broker rated Arcturus Therapeutics Buy ($27 target). BMO Capital rated Honeywell Aerospace Outperform ($276 target). Keybanc rated Waystar Holding Overweight ($30 target).
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Baird analyst Jeffrey Meuler initiated coverage on Mobility Global Inc (NYSE:MBGL) with a Neutral rating and announced a price target of $23. Mobility Global shares closed at $21.19 on Wednesday. See how other analysts view this stock.
- UBS analyst Ashwani Verma initiated coverage on Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) with a Buy rating and announced a price target of $55. Crinetics Pharmaceuticals shares closed at $38.68 on Wednesday. See how other analysts view this stock.
- Freedom Broker analyst Ilya Zubkov initiated coverage on Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) with a Buy rating and announced a price target of $27. Arcturus Therapeutics shares closed at $6.89 on Wednesday. See how other analysts view this stock.
- BMO Capital initiated coverage on Honeywell Aerospace Inc (NASDAQ:HONA) with an Outperform rating and announced a price target of $276. Honeywell Aerospace shares closed at $227.29 on Wednesday. See how other analysts view this stock.
- Keybanc analyst Scott Schoenhaus initiated coverage on Waystar Holding Corp (NASDAQ:WAY) with an Overweight rating and announced a price target of $30. Waystar shares closed at $21.43 on Wednesday. See how other analysts view this stock.
Considering buying HONA stock? Here’s what analysts think:
Photo via Shutterstock